Skip to content

MYSEUM.AI, INC.: 10-Q filed 2023-11-13

What MYSEUM.AI, INC. reported in its quarterly report filed 2023-11-13 (fiscal Q3 2023): 35 published measures, 106 facts as tagged in accession 0001213900-23-086183.

This filing

Form
10-Q (quarterly report)
Filed
2023-11-13
Fiscal period
fiscal Q3 2023
Accession
0001213900-23-086183 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MYSEUM.AI, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-307,975,661USD
At 2022-12-3113,113,690USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-30492,600USD
At 2022-12-31557,114USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-307,483,061USD
At 2023-06-309,180,882USD
At 2023-03-3110,704,249USD
At 2022-12-3112,556,576USD
At 2022-09-3015,240,879USD
At 2022-06-3017,058,795USD
At 2022-03-3117,743,026USD
At 2021-12-3120,084,014USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-09-30672,086USD
At 2022-12-311,732,956USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-2,364,580USD92
2023-01-01 to 2023-09-30-7,051,024USD273
2023-04-01 to 2023-06-30-2,287,230USD91
2023-01-01 to 2023-03-31-2,399,214USD90
2022-07-01 to 2022-09-30-2,656,705USD92
2022-01-01 to 2022-09-30-8,604,263USD273
2022-04-01 to 2022-06-30-2,581,712USD91
2022-01-01 to 2022-03-31-3,365,846USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-5,159,510USD273
2022-01-01 to 2022-09-30-5,727,584USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-09-3049,485USD273
2022-01-01 to 2022-09-3044,475USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-07-01 to 2023-09-30175USD92
2023-01-01 to 2023-09-30501USD273
2022-07-01 to 2022-09-303,540USD92
2022-01-01 to 2022-09-3042,296USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-398,284USD273
2022-01-01 to 2022-09-30-203USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-09-304,496,890USD273
2022-01-01 to 2022-09-30-8,242,060USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-30-46,780,142USD
At 2022-12-31-39,729,118USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-07-01 to 2023-09-302,088,516shares92
2023-01-01 to 2023-09-302,075,515shares273
2022-07-01 to 2022-09-302,059,742shares92
2022-01-01 to 2022-09-301,993,808shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-07-01 to 2023-09-302,088,516shares92
2023-01-01 to 2023-09-302,075,515shares273
2022-07-01 to 2022-09-302,059,742shares92
2022-01-01 to 2022-09-301,993,808shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1.13USD/shares92
2023-01-01 to 2023-09-30-3.4USD/shares273
2022-07-01 to 2022-09-30-1.29USD/shares92
2022-01-01 to 2022-09-30-4.32USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1.13USD/shares92
2023-01-01 to 2023-09-30-3.4USD/shares273
2022-07-01 to 2022-09-30-1.29USD/shares92
2022-01-01 to 2022-09-30-4.32USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-09-30108,492USD
At 2022-12-3179,694USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-09-301,979,794USD273
2022-01-01 to 2022-09-302,382,364USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-2,542,151USD92
2023-01-01 to 2023-09-30-7,355,228USD273
2022-07-01 to 2022-09-30-2,681,910USD92
2022-01-01 to 2022-09-30-8,629,155USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-307,776,915USD
At 2022-12-3112,876,089USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-30469,749USD
At 2022-12-31473,439USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-09-30142USD
At 2022-12-31384USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-07-01 to 2023-09-302,542,326USD92
2023-01-01 to 2023-09-307,355,729USD273
2022-07-01 to 2022-09-302,685,450USD92
2022-01-01 to 2022-09-308,671,451USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-07-01 to 2023-09-30380,017USD92
2023-01-01 to 2023-09-301,064,049USD273
2022-07-01 to 2022-09-30258,957USD92
2022-01-01 to 2022-09-30258,957USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-302,094,285shares
At 2022-12-312,059,717shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-09-30672,086USD
At 2022-12-311,732,956USD
At 2022-09-306,229,888USD
At 2021-12-3120,199,735USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-09-3054,551,840USD
At 2022-12-3152,285,488USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2023-09-30108,923USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-09-3090,254USD
At 2022-12-31134,526USD
At 2021-08-27198,898USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2023-09-30102,205USD
At 2022-12-31151,013USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2023-09-3078USD
At 2022-12-31186USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-2,453,985USD92
2023-01-01 to 2023-09-30-6,942,101USD273
2022-07-01 to 2022-09-30-2,656,705USD92
2022-01-01 to 2022-09-30-8,604,263USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30212,680USD92
2023-01-01 to 2023-09-30651,461USD273
2022-07-01 to 2022-09-30232,064USD92
2022-01-01 to 2022-09-30712,103USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2023-01-01 to 2023-09-3020,687USD273
2022-01-01 to 2022-09-3067,227USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-07-01 to 2023-09-30177,571USD92
2023-01-01 to 2023-09-30304,204USD273
2022-07-01 to 2022-09-3025,205USD92
2022-01-01 to 2022-09-3024,892USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-242USD273
2022-01-01 to 2022-09-30-86USD273

Inspect the source

Entity
MYSEUM.AI, INC. / CIK 0001648960
Captured
2026-09-21T17:21:51.196Z
SEC response SHA-256
73c0683f07d4b61dfa920ade74d8937aa8eb539e1c4bc6ad8c60d53105e900c8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001648960.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))